US Stock MarketDetailed Quotes

Cue Biopharma (CUE)

Watchlist
  • 23.010
  • -2.320-9.16%
Close May 15 15:59 ET
  • 22.010
  • -1.000-4.35%
Post 19:18 ET
93.09MMarket Cap-5.08P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Cue Biopharma (CUE) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-33.90%-10.94M
40.30%-21.69M
88.08%-1.08M
-19.89%-9.02M
65.82%-3.42M
16.48%-8.17M
9.09%-36.33M
17.61%-9.03M
3.49%-7.53M
3.67%-9.99M
Net income from continuing operations
57.75%-5.18M
34.60%-26.6M
116.69%1.59M
14.00%-7.45M
16.61%-8.48M
0.73%-12.26M
19.83%-40.67M
29.31%-9.5M
21.31%-8.66M
22.86%-10.17M
Operating gains losses
----
133.33%31K
-600.00%-20K
----
----
----
-159.24%-93K
-97.48%4K
---98K
----
Depreciation and amortization
5.33%929K
48.09%3.48M
606.72%1.21M
-32.04%596K
-7.66%796K
3.89%882K
-31.61%2.35M
-127.97%-238K
2.45%877K
1.53%862K
Other non cash items
-124.39%-10K
0.00%167K
0.00%41K
0.00%43K
2.44%42K
-2.38%41K
0.00%167K
0.00%41K
0.00%43K
0.00%41K
Change In working capital
-469.02%-6.73M
33.10%-3.3M
-395.89%-4.47M
-184.36%-3.62M
219.69%2.97M
765.69%1.82M
-427.30%-4.93M
-39.26%-901K
-617.07%-1.27M
-6,095.00%-2.48M
-Change in receivables
-79.37%195K
-963.21%-6.5M
-333.76%-5.16M
111.11%145K
-443.85%-2.43M
217.11%945K
145.89%753K
5,907.89%2.21M
-148.10%-1.31M
52.35%-447K
-Change in prepaid assets
22.98%-818K
-95.88%10K
169.93%1.85M
-321.18%-752K
-111.57%-25K
-6.41%-1.06M
872.00%243K
226.19%685K
-54.42%340K
-51.79%216K
-Change in payables and accrued expense
-114.90%-420K
127.11%517K
146.71%1.84M
-177.06%-927K
-388.60%-3.22M
89.25%2.82M
-240.43%-1.91M
-12,812.90%-3.94M
1.86%1.2M
-145.85%-658K
-Change in other current liabilities
55.43%-353K
-29.44%-2.57M
-260.87%-518K
36.44%-504K
2.19%-758K
-6.88%-792K
28.73%-1.99M
144.48%322K
-11.69%-793K
-10.40%-775K
-Change in other working capital
-6,176.47%-5.34M
359.00%5.25M
-1,325.86%-2.48M
-145.89%-1.76M
1,276.78%9.58M
73.60%-85K
-195.98%-2.03M
-38.10%-174K
-61.12%-717K
-187.63%-814K
Cash from discontinued investing activities
Operating cash flow
-33.90%-10.94M
40.30%-21.69M
88.08%-1.08M
-19.89%-9.02M
65.82%-3.42M
16.48%-8.17M
9.09%-36.33M
17.61%-9.03M
3.49%-7.53M
3.67%-9.99M
Investing cash flow
Cash flow from continuing investing activities
19.33%-121K
134.38%75K
702,100.00%7.02M
-7,006.12%-6.77M
-170.00%-27K
-172.73%-150K
-99.87%32K
-1K
-98.04%98K
-100.20%-10K
Net PPE purchase and sale
19.33%-121K
-528.13%-137K
2,100.00%20K
-79.59%20K
-170.00%-27K
-172.73%-150K
1,500.00%32K
---1K
--98K
---10K
Net investment purchase and sale
----
--212K
--7M
----
----
----
--0
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
19.33%-121K
134.38%75K
702,100.00%7.02M
-7,006.12%-6.77M
-170.00%-27K
-172.73%-150K
-99.87%32K
---1K
-98.04%98K
-100.20%-10K
Financing cash flow
Cash flow from continuing financing activities
130.60%306K
156.67%26.29M
1,118.45%9.49M
-99.99%1K
1,879.80%17.8M
-142.48%-1M
-13.63%10.24M
-119.49%-932K
114.01%9.82M
-147.60%-1M
Net issuance payments of debt
--0
-12.53%-4.5M
-50.15%-1.5M
0.00%-1M
0.00%-1M
0.00%-1M
-99.95%-4M
0.10%-999K
0.00%-1M
---1M
Net common stock issuance
--306K
116.47%30.79M
22,332.65%10.99M
-90.75%1M
--18.8M
--0
6.25%14.22M
-99.15%49K
93.61%10.82M
--0
Proceeds from stock option exercised by employees
----
--0
----
----
----
----
-96.19%18K
--18K
--0
--0
Cash from discontinued financing activities
Financing cash flow
130.60%306K
156.67%26.29M
1,118.45%9.49M
-99.99%1K
1,879.80%17.8M
-142.48%-1M
-13.63%10.24M
-119.49%-932K
114.01%9.82M
-147.60%-1M
Net cash flow
Beginning cash position
20.69%27.29M
-53.54%22.61M
-63.61%11.85M
-8.40%27.65M
-67.73%13.29M
-53.54%22.61M
-5.99%48.67M
-40.61%32.57M
-43.11%30.18M
-26.88%41.18M
Current changes in cash
-15.39%-10.76M
117.96%4.68M
254.96%15.44M
-760.16%-15.79M
230.51%14.36M
-24.54%-9.32M
-740.72%-26.05M
-61.29%-9.96M
33.63%2.39M
-236.39%-11M
End cash Position
24.41%16.53M
20.69%27.29M
20.69%27.29M
-63.61%11.85M
-8.40%27.65M
-67.73%13.29M
-53.54%22.61M
-53.54%22.61M
-40.61%32.57M
-43.11%30.18M
Free cash flow
-32.94%-11.06M
39.93%-21.86M
88.08%-1.08M
-19.90%-9.02M
65.58%-3.44M
15.42%-8.32M
8.92%-36.4M
17.59%-9.03M
3.50%-7.53M
3.58%-10M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -33.90%-10.94M40.30%-21.69M88.08%-1.08M-19.89%-9.02M65.82%-3.42M16.48%-8.17M9.09%-36.33M17.61%-9.03M3.49%-7.53M3.67%-9.99M
Net income from continuing operations 57.75%-5.18M34.60%-26.6M116.69%1.59M14.00%-7.45M16.61%-8.48M0.73%-12.26M19.83%-40.67M29.31%-9.5M21.31%-8.66M22.86%-10.17M
Operating gains losses ----133.33%31K-600.00%-20K-------------159.24%-93K-97.48%4K---98K----
Depreciation and amortization 5.33%929K48.09%3.48M606.72%1.21M-32.04%596K-7.66%796K3.89%882K-31.61%2.35M-127.97%-238K2.45%877K1.53%862K
Other non cash items -124.39%-10K0.00%167K0.00%41K0.00%43K2.44%42K-2.38%41K0.00%167K0.00%41K0.00%43K0.00%41K
Change In working capital -469.02%-6.73M33.10%-3.3M-395.89%-4.47M-184.36%-3.62M219.69%2.97M765.69%1.82M-427.30%-4.93M-39.26%-901K-617.07%-1.27M-6,095.00%-2.48M
-Change in receivables -79.37%195K-963.21%-6.5M-333.76%-5.16M111.11%145K-443.85%-2.43M217.11%945K145.89%753K5,907.89%2.21M-148.10%-1.31M52.35%-447K
-Change in prepaid assets 22.98%-818K-95.88%10K169.93%1.85M-321.18%-752K-111.57%-25K-6.41%-1.06M872.00%243K226.19%685K-54.42%340K-51.79%216K
-Change in payables and accrued expense -114.90%-420K127.11%517K146.71%1.84M-177.06%-927K-388.60%-3.22M89.25%2.82M-240.43%-1.91M-12,812.90%-3.94M1.86%1.2M-145.85%-658K
-Change in other current liabilities 55.43%-353K-29.44%-2.57M-260.87%-518K36.44%-504K2.19%-758K-6.88%-792K28.73%-1.99M144.48%322K-11.69%-793K-10.40%-775K
-Change in other working capital -6,176.47%-5.34M359.00%5.25M-1,325.86%-2.48M-145.89%-1.76M1,276.78%9.58M73.60%-85K-195.98%-2.03M-38.10%-174K-61.12%-717K-187.63%-814K
Cash from discontinued investing activities
Operating cash flow -33.90%-10.94M40.30%-21.69M88.08%-1.08M-19.89%-9.02M65.82%-3.42M16.48%-8.17M9.09%-36.33M17.61%-9.03M3.49%-7.53M3.67%-9.99M
Investing cash flow
Cash flow from continuing investing activities 19.33%-121K134.38%75K702,100.00%7.02M-7,006.12%-6.77M-170.00%-27K-172.73%-150K-99.87%32K-1K-98.04%98K-100.20%-10K
Net PPE purchase and sale 19.33%-121K-528.13%-137K2,100.00%20K-79.59%20K-170.00%-27K-172.73%-150K1,500.00%32K---1K--98K---10K
Net investment purchase and sale ------212K--7M--------------0--0--0--0
Cash from discontinued investing activities
Investing cash flow 19.33%-121K134.38%75K702,100.00%7.02M-7,006.12%-6.77M-170.00%-27K-172.73%-150K-99.87%32K---1K-98.04%98K-100.20%-10K
Financing cash flow
Cash flow from continuing financing activities 130.60%306K156.67%26.29M1,118.45%9.49M-99.99%1K1,879.80%17.8M-142.48%-1M-13.63%10.24M-119.49%-932K114.01%9.82M-147.60%-1M
Net issuance payments of debt --0-12.53%-4.5M-50.15%-1.5M0.00%-1M0.00%-1M0.00%-1M-99.95%-4M0.10%-999K0.00%-1M---1M
Net common stock issuance --306K116.47%30.79M22,332.65%10.99M-90.75%1M--18.8M--06.25%14.22M-99.15%49K93.61%10.82M--0
Proceeds from stock option exercised by employees ------0-----------------96.19%18K--18K--0--0
Cash from discontinued financing activities
Financing cash flow 130.60%306K156.67%26.29M1,118.45%9.49M-99.99%1K1,879.80%17.8M-142.48%-1M-13.63%10.24M-119.49%-932K114.01%9.82M-147.60%-1M
Net cash flow
Beginning cash position 20.69%27.29M-53.54%22.61M-63.61%11.85M-8.40%27.65M-67.73%13.29M-53.54%22.61M-5.99%48.67M-40.61%32.57M-43.11%30.18M-26.88%41.18M
Current changes in cash -15.39%-10.76M117.96%4.68M254.96%15.44M-760.16%-15.79M230.51%14.36M-24.54%-9.32M-740.72%-26.05M-61.29%-9.96M33.63%2.39M-236.39%-11M
End cash Position 24.41%16.53M20.69%27.29M20.69%27.29M-63.61%11.85M-8.40%27.65M-67.73%13.29M-53.54%22.61M-53.54%22.61M-40.61%32.57M-43.11%30.18M
Free cash flow -32.94%-11.06M39.93%-21.86M88.08%-1.08M-19.90%-9.02M65.58%-3.44M15.42%-8.32M8.92%-36.4M17.59%-9.03M3.50%-7.53M3.58%-10M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +34.01%
Sample Name
Sample Code
 +27.74%
Sample Name
Sample Code
 +26.87%
4
United States Gasoline Fund Lp
UGA
+26.33%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+20.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.54%
Sample Name
Sample Code
 +10.70%
Sample Name
Sample Code
 +6.24%
4
NIO Inc
NIO
+4.27%
5
Hesai
HSAI
+3.89%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -